122 related articles for article (PubMed ID: 7008557)
1. Dermal copper drugs: the copper bracelet and cu(II) salicylate complexes.
Walker WR; Beveridge SJ; Whitehouse MW
Agents Actions Suppl; 1981; 8():359-67. PubMed ID: 7008557
[TBL] [Abstract][Full Text] [Related]
2. An investigation of the therapeutic value of the 'copper bracelet'-dermal assimilation of copper in arthritic/rheumatoid conditions.
Walker WR; Keats DM
Agents Actions; 1976 Jul; 6(4):454-9. PubMed ID: 961545
[TBL] [Abstract][Full Text] [Related]
3. Ternary copper (II) complexes containing salicylate and nitrogenous chelates such as histamine.
Walker WR; Reeves R
Agents Actions Suppl; 1977; (1):109-17. PubMed ID: 272824
[TBL] [Abstract][Full Text] [Related]
4. Copper salicylate as an anti-inflammatory and analgesic agent in arthritic rats.
Jacka T; Bernard CC; Singer G
Life Sci; 1983 Feb; 32(9):1023-30. PubMed ID: 6600809
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution of 64Cu in rats after topical application of two lipophilic anti-inflammatory Cu(II) formulations.
Beveridge SJ; Boettcher B; Walker WR; Whitehouse MW
Agents Actions; 1984 Feb; 14(2):291-5. PubMed ID: 6711390
[TBL] [Abstract][Full Text] [Related]
6. Lipophilic copper(II) formulations: some correlations between their composition and anti-inflammatory/anti-arthritic activity when applied to the skin of rats.
Beveridge SJ; Whitehouse MW; Walker WR
Agents Actions; 1982 Apr; 12(1-2):225-31. PubMed ID: 7080960
[TBL] [Abstract][Full Text] [Related]
7. The "copper bracelet" for arthritis.
Whitehouse MW; Walker WR
Med J Aust; 1977 Jun; 1(25):938. PubMed ID: 887030
[No Abstract] [Full Text] [Related]
8. Anti-inflammatory activity of a dermally applied copper salicylate preparation (Alcusal).
Walker WR; Beveridge SJ; Whitehouse MW
Agents Actions; 1980 Apr; 10(1 Pt 2):38-47. PubMed ID: 7386307
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory activity of copper salicylates applied to rats percutaneously in dimethyl sulphoxide with glycerol.
Beveridge SJ; Walker WR; Whitehouse MW
J Pharm Pharmacol; 1980 Jun; 32(6):425-7. PubMed ID: 6106677
[No Abstract] [Full Text] [Related]
10. Treatment of rheumatoid and degenerative diseases with copper complexes: a review with emphasis on copper-salicylate.
Sorenson JR; Hangarter W
Inflammation; 1977 Sep; 2(3):217-38. PubMed ID: 367963
[TBL] [Abstract][Full Text] [Related]
11. [Copper salicylate in rheumatoid arthritis and rheumatism--like degenerative diseases].
Hangarter W
Med Welt; 1980 Nov; 31(45):1625-8. PubMed ID: 6969838
[No Abstract] [Full Text] [Related]
12. Assessment of triethanolamine salicylate release from the dermatological bases and the commercial products.
Babar A; Chickhale PJ; Plakogiannis FM
Pharm Acta Helv; 1991; 66(12):322-8. PubMed ID: 1784579
[TBL] [Abstract][Full Text] [Related]
13. Copper salicylate compounds.
Walker WR
Med J Aust; 1987 Jul; 147(2):104-6. PubMed ID: 3600451
[No Abstract] [Full Text] [Related]
14. [Antiexsudative activity of (methylsalicylate)copper-water compounds].
Sokolík J; Tumová I; Blahová M; Cellárová M; Svajlenová O; Svec P
Ceska Slov Farm; 1995 Aug; 44(4):212-4. PubMed ID: 7663874
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of the analgesic effect of magnesium salicylate.
Stern SB
Med Times; 1967 Oct; 95(10):1072-6. PubMed ID: 4866037
[No Abstract] [Full Text] [Related]
16. Percutaneous absorption of salicylates from some commercially available topical products containing methyl salicylate or salicylate salts in rats.
Megwa SA; Benson HA; Roberts MS
J Pharm Pharmacol; 1995 Nov; 47(11):891-6. PubMed ID: 8708981
[TBL] [Abstract][Full Text] [Related]
17. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
[TBL] [Abstract][Full Text] [Related]
18. Tetranuclear copper(II) complexes bridged by alpha-D-glucose-1-phosphate and incorporation of sugar acids through the Cu4 core structural changes.
Kato M; Sah AK; Tanase T; Mikuriya M
Inorg Chem; 2006 Aug; 45(17):6646-60. PubMed ID: 16903719
[TBL] [Abstract][Full Text] [Related]
19. Potential dangers from topical preparations containing methyl salicylate.
Chan TY
Hum Exp Toxicol; 1996 Sep; 15(9):747-50. PubMed ID: 8880210
[TBL] [Abstract][Full Text] [Related]
20. Copper(II) complexes of tridentate pyridylmethylethylenediamines: role of ligand steric hindrance on DNA binding and cleavage.
Raja A; Rajendiran V; Uma Maheswari P; Balamurugan R; Kilner CA; Halcrow MA; Palaniandavar M
J Inorg Biochem; 2005 Aug; 99(8):1717-32. PubMed ID: 16039720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
